日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

碳酸酐酶 9 作为循环生物标志物和治疗靶点在接受阿特珠单抗联合贝伐珠单抗治疗的肝细胞癌患者中的应用

Sato, Yu; Kodama, Takahiro; Maesaka, Kazuki; Kai, Machiko; Murai, Kazuhiro; Tahata, Yuki; Saito, Yoshinobu; Nakabori, Tasuku; Ohkawa, Kazuyoshi; Tanaka, Satoshi; Sakamori, Ryotaro; Miyazaki, Masanori; Furuta, Kunimaro; Ishida, Hisashi; Matsumoto, Kengo; Tawara, Seiichi; Yakushijin, Takayuki; Nozaki, Yasutoshi; Hosui, Atsushi; Nishio, Akira; Tatsumi, Nobuyuki; Kakita, Naruyasu; Yoo, Changhoon; Fukai, Moto; Taketomi, Akinobu; Hikita, Hayato; Tatsumi, Tomohide; Takehara, Tetsuo

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma.

系统性免疫分析揭示了肝细胞癌联合免疫疗法反应的不同机制和预测性生物标志物。

Nishio Akira, Kodama Takahiro, Daiku Kazuma, Maesaka Kazuki, Tanaka Satoshi, Nozaki Yasutoshi, Kurahashi Tomohide, Matsumoto Kengo, Nawa Takatoshi, Tawara Seiichi, Tokuda Yuki, Nakabori Tasuku, Sakamori Ryotaro, Ohkawa Kazuyoshi, Miyazaki Masanori, Yamamoto Shuhei, Shigeno Satoshi, Myojin Yuta, Tahata Yuki, Hikita Hayato, Takehara Tetsuo

Liver Sinusoidal Endothelial Cells Promote Metabolic Dysfunction-associated Steatohepatitis Progression via Interleukin-1R1-mediated Chemokine Production Induced by Macrophage-derived Interleukin-1β.

肝窦内皮细胞通过巨噬细胞衍生的白细胞介素-1β诱导的白细胞介素-1R1介导的趋化因子产生,促进代谢功能障碍相关的脂肪性肝炎进展。

Fukumoto Kenji, Hikita Hayato, Saito Yoshinobu, Makino Yuki, Soma Kazumasa, Kato Seiya, Sasaki Yoichi, Myojin Yuta, Sato Katsuhiko, Sakane Sadatsugu, Murai Kazuhiro, Tahata Yuki, Kodama Takahiro, Tatsumi Tomohide, Motooka Daisuke, Kubota Yoshiaki, Kobayashi Shogo, Eguchi Hidetoshi, Takehara Tetsuo

Auranofin, identified by FDA-approved drug library screening, inhibits HBs antigen secretion via lysosomal damage

金诺芬(Auranofin)是通过FDA批准的药物库筛选发现的,它通过溶酶体损伤抑制HBs抗原的分泌。

Shimoda, Akiyoshi; Murai, Kazuhiro; Hikita, Hayato; Minami, Satoshi; Miyake, Takayuki; Kuriki, Shinji; Sometani, Emi; Sung, Jihyun; Shigeno, Satoshi; Higuchi, Yuichiro; Maesaka, Kazuki; Shirai, Kumiko; Tahata, Yuki; Saito, Yoshinobu; Kodama, Takahiro; Takahashi, Takeshi; Suemizu, Hiroshi; Takehara, Tetsuo

Folate receptor 1 is a stemness trait-associated diagnostic and prognostic marker for hepatocellular carcinoma

叶酸受体 1 是肝细胞癌的干性特征相关诊断和预后标志物

Yuto Shiode #, Takahiro Kodama #, Yu Sato, Ryo Takahashi, Takayuki Matsumae, Kumiko Shirai, Akira Doi, Yuki Tahata, Hayato Hikita, Tomohide Tatsumi, Moto Fukai, Akinobu Taketomi, Mathuros Ruchirawat, Xin Wei Wang, Tetsuo Takehara

Histological improvement of fibrosis in patients with hepatitis C who achieved a 5-year sustained virological response to treatment with direct-acting antivirals

接受直接抗病毒药物治疗并获得5年持续病毒学应答的丙型肝炎患者的纤维化组织学改善

Iwamoto, Takayuki; Nozaki, Yasutoshi; Inoue, Takanori; Suda, Takahiro; Mizumoto, Rui; Arimoto, Yuki; Ohta, Takashi; Yamaguchi, Shinjiro; Ito, Yoshiki; Sudo, Yoshiko; Yoshimura, Michiko; Kai, Machiko; Sasaki, Yoichi; Tahata, Yuki; Hikita, Hayato; Takehara, Tetsuo; Hagiwara, Hideki

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

高血压作为一种不良事件,可能影响阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的疗效

Maesaka, Kazuki; Hikita, Hayato; Kai, Machiko; Tahata, Yuki; Shirai, Kumiko; Doi, Akira; Murai, Kazuhiro; Saito, Yoshinobu; Yamada, Ryoko; Kodama, Takahiro; Ohkawa, Kazuyoshi; Miyazaki, Masanori; Ishida, Hisashi; Matsumoto, Kengo; Nozaki, Yasutoshi; Yakushijin, Takayuki; Sakamori, Ryotaro; Tatsumi, Nobuyuki; Iio, Sadaharu; Nawa, Takatoshi; Kakita, Naruyasu; Nakahara, Masanori; Hosui, Atsushi; Usui, Takeo; Imanaka, Kazuho; Doi, Yoshinori; Sakakibara, Mitsuru; Yoshida, Yuichi; Tatsumi, Tomohide; Takehara, Tetsuo

Complete Response of Hepatocellular Carcinoma With Inferior Vena Cava Tumor Thrombus and Right Atrium Involvement to Combined Radiotherapy and Immunotherapy: A Case Report

肝细胞癌伴下腔静脉瘤栓及右心房受累患者接受放疗联合免疫治疗后完全缓解:病例报告

Daiku, Kazuma; Nishio, Akira; Hikita, Hayato; Doi, Akira; Hayashi, Kazuhiko; Kato, Seiya; Sasaki, Yoichi; Shimoda, Akiyoshi; Kudo, Shinnosuke; Fukumoto, Kenji; Maesaka, Kazuki; Matsumae, Takayuki; Shirai, Kumiko; Sato, Katsuhiko; Murai, Kazuhiro; Tahata, Yuki; Yoshioka, Teppei; Furuta, Kunimaro; Kodama, Takahiro; Tatsumi, Tomohide; Ogawa, Kazuhiko; Takehara, Tetsuo

Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD

血清细胞外囊泡的蛋白质组学分析表明 Fibulin-3 是预测 MASLD 中肝脏相关事件的新标志物

Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Tatsuya Sakamoto, Ryohei Narumi, Jun Adachi, Naruyasu Kakita, Yukinori Yamada, Hidenori Toyoda, Hirokazu Takahashi, Goki Suda, Machiko Kai, Yuki Tahata, Ryotaro Sakamori, Shusuke Kumazaki, Kenji Fukumoto, Yuta Myojin, Kazuhiro Murai, Takahiro Kodama, T

Endoscopic and Histological Characteristics of Gastric Cancer Detected Long After Helicobacter pylori Eradication Therapy

幽门螺杆菌根除治疗后很久才发现的胃癌的内镜和组织学特征

Abe, Ryo; Uchikoshi, Shu; Horikawa, Yohei; Mimori, Nobuya; Kato, Yuhei; Tahata, Yuta; Fushimi, Saki; Saito, Masahiro; Takahashi, Satsuki